BRIEF-AstraZeneca Says Less Than 1% Of Patients Treated With Calquence Discontinued Treatment Due To Cardiac Adverse Events In Pooled Analysis
AstraZeneca PLC:
* ASTRAZENECA - LESS THAN 1% OF PATIENTS TREATED WITH CALQUENCE DISCONTINUED TREATMENT DUE TO CARDIAC ADVERSE EVENTS IN POOLED ANALYSIS Source text for Eikon: Further company coverage:
Google News